ARCH Venture
VC firm · Chicago, IL
Verified active in the last 12 monthsSEC-registered adviser
Venture firm based in Chicago, IL. Most recent fund on file: ARCH Venture Fund XIV, L.P. ($3.0B offering), filed Aug 2026. Partners sit on the boards of 21 startups that raised recently.
“ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences” (from the firm’s website)
- Stages
- Seed to Growth
- Typical check (est.)
- $4.05M–$92.5M
- Latest fund
- $3B · Aug 2026
- Last verified activity
- Aug 2026
Focus
Biotech & PharmaHealthcareRecent portfolio activity
- Jun 2026
SonoThera
Board seat · CA
- Jun 2026
Ollin Biosciences
Board seat · TX
- Oct 2025
Pheast Therapeutics
Board seat · CA
- Feb 2025
Areteia Therapeutics
Board seat · NC
- Dec 2024
Cytrellis Biosystems
Board seat · MA
- Nov 2024
Metsera
Board seat · NY
- Oct 2024
Seaport Therapeutics
Board seat · MA
- Oct 2024
Vizgen
Board seat · MA
- Oct 2024
Treeline Biosciences
Board seat · MA
- Oct 2024
RIPPL Care
Board seat · WA
- Aug 2024
Autobahn Therapeutics
Board seat · CA
- Jul 2024
Ultivue
Board seat · MA
- Apr 2024
Mirador Therapeutics
Board seat · CA
- Feb 2024
eGenesis
Board seat · MA
- Jan 2024
Elephas Biosciences
Board seat · WI
Funds and vehicles on SEC file
Sources
- SEC Form D: ARCH Venture Fund XIV, L.P.Aug 31, 2026
- SEC Form D: ARCH Venture Fund XIII, L.P.Feb 1, 2024
- SEC adviser record: ARCH Venture PartnersMar 30, 2026
- Firm websiteOct 12, 2026
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.